Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Taieb, Julien, Prof, Tabernero, Josep, Prof, Mini, Enrico, Prof, Subtil, Fabien, PhD, Folprecht, Gunnar, MD, Van Laethem, Jean-Luc, Prof, Thaler, Josef, Prof, Bridgewater, John, MD, Petersen, Lone Nørgård, Prof, Blons, Hélène, PhD, Collette, Laurence, PhD, Van Cutsem, Eric, Prof, Rougier, Philippe, Prof, Salazar, Ramon, Prof, Bedenne, Laurent, Prof, Emile, Jean-François, Prof, Laurent-Puig, Pierre, Prof, Lepage, Come, Prof
Published in The lancet oncology (01.07.2014)
Published in The lancet oncology (01.07.2014)
Get full text
Journal Article
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
Rödel, Claus, Prof, Liersch, Torsten, MD, Becker, Heinz, Prof, Fietkau, Rainer, Prof, Hohenberger, Werner, Prof, Hothorn, Torsten, Prof, Graeven, Ullrich, MD, Arnold, Dirk, Prof, Lang-Welzenbach, Marga, MSc, Raab, Hans-Rudolf, Prof, Sülberg, Heiko, MSc, Wittekind, Christian, Prof, Potapov, Sergej, MSc, Staib, Ludger, Prof, Hess, Clemens, Prof, Weigang-Köhler, Karin, MD, Grabenbauer, Gerhard G, Prof, Hoffmanns, Hans, MD, Lindemann, Fritz, MD, Schlenska-Lange, Anke, MD, Folprecht, Gunnar, MD, Sauer, Rolf, Prof
Published in The lancet oncology (01.07.2012)
Published in The lancet oncology (01.07.2012)
Get full text
Journal Article